Essec\Faculty\Model\Contribution {#6196
#_index: "academ_contributions"
#_id: "1151"
#_source: array:26 [
"id" => "1151"
"slug" => "evaluation-of-cost-savings-with-ferric-carboxymaltose-in-anemia-treatment-through-its-impact-on-erythropoiesis-stimulating-agents-and-blood-transfusion-french-healthcare-payer-perspective"
"yearMonth" => "2012-01"
"year" => "2012"
"title" => "Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective"
"description" => "LUPORSI, E., MAHI, L., MORRE, C., WERNLI, J., PUYOU DE POUVOURVILLE, G. et BUGAT, R. (2012). Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective. <i>Journal of Medical Economics</i>, 15(2), pp. 225-232."
"authors" => array:6 [
0 => array:3 [
"name" => "PUYOU DE POUVOURVILLE Gérard"
"bid" => "B00072308"
"slug" => "puyou-de-pouvourville-gerard"
]
1 => array:1 [
"name" => "LUPORSI E."
]
2 => array:1 [
"name" => "MAHI L."
]
3 => array:1 [
"name" => "MORRE C."
]
4 => array:1 [
"name" => "WERNLI J."
]
5 => array:1 [
"name" => "BUGAT R."
]
]
"ouvrage" => ""
"keywords" => array:3 [
0 => "Anemia"
1 => "Intravenous iron"
2 => "Erythropoiesis-stimulating agents"
]
"updatedAt" => "2021-07-13 14:30:14"
"publicationUrl" => "https://www.tandfonline.com/doi/abs/10.3111/13696998.2011.639823"
"publicationInfo" => array:3 [
"pages" => "225-232"
"volume" => "15"
"number" => "2"
]
"type" => array:2 [
"fr" => "Articles"
"en" => "Journal articles"
]
"support_type" => array:2 [
"fr" => "Revue scientifique"
"en" => "Scientific journal"
]
"countries" => array:2 [
"fr" => null
"en" => null
]
"abstract" => array:2 [
"fr" => "This article evaluates the economic impact of intravenous iron (in the form of intravenous iron preparation of ferric carboxymaltose) in three different clinical settings of iron deficiency anemia: chemotherapy-induced anemia in breast cancer, chemotherapy-induced anemia in digestive cancer, and perioperative anemia in knee and hip surgery."
"en" => "This article evaluates the economic impact of intravenous iron (in the form of intravenous iron preparation of ferric carboxymaltose) in three different clinical settings of iron deficiency anemia: chemotherapy-induced anemia in breast cancer, chemotherapy-induced anemia in digestive cancer, and perioperative anemia in knee and hip surgery."
]
"authors_fields" => array:2 [
"fr" => "Economie"
"en" => "Economics"
]
"indexedAt" => "2024-04-18T23:22:03.000Z"
"docTitle" => "Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective"
"docSurtitle" => "Articles"
"authorNames" => "<a href="/cv/puyou-de-pouvourville-gerard">PUYOU DE POUVOURVILLE Gérard</a>, LUPORSI E., MAHI L., MORRE C., WERNLI J., BUGAT R."
"docDescription" => "<span class="document-property-authors">PUYOU DE POUVOURVILLE Gérard, LUPORSI E., MAHI L., MORRE C., WERNLI J., BUGAT R.</span><br><span class="document-property-authors_fields">Economie</span> | <span class="document-property-year">2012</span>"
"keywordList" => "<a href="#">Anemia</a>, <a href="#">Intravenous iron</a>, <a href="#">Erythropoiesis-stimulating agents</a>"
"docPreview" => "<b>Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective</b><br><span>2012-01 | Articles </span>"
"docType" => "research"
"publicationLink" => "<a href="https://www.tandfonline.com/doi/abs/10.3111/13696998.2011.639823" target="_blank">Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective</a>"
]
+lang: "fr"
+"_type": "_doc"
+"_score": 9.204859
+"parent": null
}
